Safal Herbs Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 10.00 Cr
as on 08-12-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -50.17%
(FY 2020)
- Profit 105.83%
(FY 2020)
- Ebitda 107.87%
(FY 2020)
- Net Worth 0.02%
(FY 2020)
- Total Assets -0.48%
(FY 2020)
About Safal Herbs
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532034.
The Corporate was formerly known as Parikh Herbals Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Safal Herbs Limited India is Partha Prasad as CFO. Partha Prasad, Priya Gautam, and Arushi Nigam serve as directors at the Company.
- CIN/LLPIN
L24233DL1994PLC290133
- Company No.
290133
- Stock Symbol
BSE : 532034
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Sep 1994
- Date of AGM
29 Sep 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Safal Herbs?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arushi Nigam  | Managing Director | 29-Oct-2021 | Current |
| Partha Prasad | CFO | 10-Sep-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priya Gautam | Director | 01-Apr-2021 | Current |
| Partha Prasad | Additional Director | 10-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Safal Herbs.
Safal Herbs Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 50.17% decrease. The company also saw a substantial improvement in profitability, with a 105.83% increase in profit. The company's net worth moved up by a moderate rise of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Safal Herbs?
In 2020, Safal Herbs had a promoter holding of 9.62% and a public holding of 90.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Safal Herbs?
Unlock and access historical data on people associated with Safal Herbs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Safal Herbs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safal Herbs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
